Egalet Announces Topline Results From Bioequivalence Studies of Abuse-Deterrent Morphine, Egalet-001

By: via Benzinga
Egalet Corporation (Nasdaq: EGLT) ("Egalet") today announced that we have top-line results from two of the three bioequivalence (BE) ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.